These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31026083)

  • 1. Intravenous flucloxacillin treatment is associated with a high incidence of hypokalaemia.
    van der Heijden CDCC; Duizer ML; Fleuren HWHA; Veldman BA; Sprong T; Dofferhoff ATSM; Kramers C
    Br J Clin Pharmacol; 2019 Dec; 85(12):2886-2890. PubMed ID: 31026083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flucloxacillin-induced hypokalaemia: a case report.
    De Backer E; Hannon H
    Acta Clin Belg; 2018 Dec; 73(6):435-438. PubMed ID: 29447079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors.
    Leegwater E; Westgeest AC; Schippers EF; Wilms EB; van Nieuwkoop C; Visser LE
    Br J Clin Pharmacol; 2022 Jun; 88(6):2938-2945. PubMed ID: 35060153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypokalaemia caused by flucloxacillin.
    Hoorn EJ; Zietse R
    J Antimicrob Chemother; 2008 Jun; 61(6):1396-8. PubMed ID: 18388113
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity.
    Kwong JC; Urbancic K; Trubiano JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.
    Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA
    Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzylpenicillin versus flucloxacillin for penicillin-susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study.
    Henderson A; Harris P; Hartel G; Paterson D; Turnidge J; Davis JS; Tong SYC
    Int J Antimicrob Agents; 2019 Oct; 54(4):491-495. PubMed ID: 31181352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of the risk of liver injury associated with flucloxacillin: a UK population-based cohort study.
    Wing K; Bhaskaran K; Pealing L; Root A; Smeeth L; van Staa TP; Klungel OH; Reynolds RF; Douglas I
    J Antimicrob Chemother; 2017 Sep; 72(9):2636-2646. PubMed ID: 28859440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement.
    Challagundla SR; Knox D; Hawkins A; Hamilton D; W V Flynn R; Robertson S; Isles C
    Nephrol Dial Transplant; 2013 Mar; 28(3):612-9. PubMed ID: 23197677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients.
    Campbell PO; Chin PKL; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
    Int J Antimicrob Agents; 2023 Jan; 61(1):106695. PubMed ID: 36464153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucloxacillin associated neutropenia in children treated for bone and joint infections (J. Paediatr. Child Health 2005; 41: 48-51).
    Pietroni M
    J Paediatr Child Health; 2005; 41(9-10):534. PubMed ID: 16150078
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis.
    Ibrahim LF; Huang L; Hopper SM; Dalziel K; Babl FE; Bryant PA
    Lancet Infect Dis; 2019 Oct; 19(10):1101-1108. PubMed ID: 31420292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flucloxacillin treatment of Staphylococcus aureus meningitis.
    Ritchie SR; Rupali P; Roberts SA; Thomas MG
    Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):501-4. PubMed ID: 17554568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucloxacillin and paracetamol induced pyroglutamic acidosis.
    Zand Irani A; Borchert G; Craven B; Gibbons H
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33419747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
    Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
    Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Disseminated Infection with Emerging Lineage of Methicillin-Sensitive Staphylococcus aureus.
    Jewell P; Dixon L; Singanayagam A; Ghani R; Wong E; Coleman M; Pichon B; Kearns A; Russell G; Hatcher J
    Emerg Infect Dis; 2019 Jan; 25(1):187-189. PubMed ID: 30561304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.